Synovus Financial Corp Has $113.79 Million Stock Holdings in Aflac Incorporated (NYSE:AFL)

Synovus Financial Corp cut its stake in Aflac Incorporated (NYSE:AFL - Free Report) by 7.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,100,074 shares of the financial services provider's stock after selling 94,806 shares during the period. Aflac makes up about 1.4% of Synovus Financial Corp's holdings, making the stock its 13th largest holding. Synovus Financial Corp owned approximately 0.20% of Aflac worth $113,792,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently added to or reduced their stakes in the company. Whipplewood Advisors LLC acquired a new stake in Aflac in the fourth quarter valued at approximately $26,000. BankPlus Trust Department acquired a new stake in shares of Aflac in the 4th quarter worth $34,000. Curio Wealth LLC acquired a new position in Aflac during the fourth quarter worth about $36,000. OFI Invest Asset Management acquired a new position in Aflac during the fourth quarter worth about $38,000. Finally, Rialto Wealth Management LLC acquired a new position in shares of Aflac in the fourth quarter worth $41,000. Hedge funds and other institutional investors own 67.44% of the company's stock.

Aflac Stock Up 0.0 %

Shares of Aflac stock traded up $0.01 on Friday, hitting $107.35. 2,294,639 shares of the company traded hands, compared to its average volume of 2,143,134. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a 12-month low of $80.11 and a 12-month high of $115.50. The company has a 50-day moving average price of $106.64 and a 200 day moving average price of $107.37. The company has a market cap of $58.59 billion, a PE ratio of 11.18, a PEG ratio of 3.24 and a beta of 0.81.

Aflac (NYSE:AFL - Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. Sell-side analysts predict that Aflac Incorporated will post 6.88 earnings per share for the current year.

Insider Buying and Selling

In other Aflac news, Director Charles D. Lake II sold 29,802 shares of the firm's stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $107.29, for a total value of $3,197,456.58. Following the sale, the director now owns 49,962 shares of the company's stock, valued at $5,360,422.98. This trade represents a 37.36 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Joseph L. Moskowitz sold 1,000 shares of the firm's stock in a transaction on Friday, March 7th. The stock was sold at an average price of $107.63, for a total transaction of $107,630.00. Following the completion of the sale, the director now owns 25,393 shares in the company, valued at approximately $2,733,048.59. The trade was a 3.79 % decrease in their position. The disclosure for this sale can be found here. 0.90% of the stock is owned by insiders.

Wall Street Analyst Weigh In

AFL has been the topic of a number of research analyst reports. JPMorgan Chase & Co. lifted their price target on shares of Aflac from $94.00 to $96.00 and gave the company a "neutral" rating in a report on Wednesday, April 2nd. Keefe, Bruyette & Woods lowered their target price on Aflac from $107.00 to $104.00 and set a "market perform" rating for the company in a research note on Wednesday, February 12th. BMO Capital Markets started coverage on shares of Aflac in a research note on Thursday, January 23rd. They issued a "market perform" rating and a $111.00 price target for the company. UBS Group lifted their price target on Aflac from $109.00 to $114.00 and gave the stock a "neutral" rating in a research note on Wednesday, April 2nd. Finally, Piper Sandler raised their price target on shares of Aflac from $118.00 to $124.00 and gave the stock an "overweight" rating in a research report on Wednesday, April 2nd. Two research analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, Aflac presently has an average rating of "Hold" and an average price target of $103.93.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.